vaccines
DomesticBiological Product
益赛普
Generic name：注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白
三生国健药业(上海)股份有限公司
Drug Information
| Generic name | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 |
|---|---|
| Trade name | 益赛普 |
| Dosage form | Injection |
| Specification | 25mg/瓶 |
| Category | Biological Product |
| Approval no. | 国药准字S20050059 |
| Drug code | 86900835000018 |
| Manufacturer | 三生国健药业(上海)股份有限公司 |
| Production address | 中国（上海）自由贸易试验区李冰路399号 |
| Origin | Domestic |
| Approval date | 2019-12-27 |
Source: NMPA (National Medical Products Administration) drug registration data, for reference only. This page does not include dosage or indications; follow your doctor's advice and read the package insert.